References
- Balkrishnan R, McMichael AJ, Hu JY, Camacho FT, Shew KR, Bouloc A, et al. Correlates of health-related quality of life in women with severe facial blemishes. Int J Dermatol. 2006; 45: 111–15
- Nicholson K, Abramova L, Chren MM, Yeung J, Chon SY, Chen SC. A pilot quality-of-life instrument for acne rosacea. J Am Acad Dermatol. 2007; 57: 213–21
- Bergfeld WF. A lifetime of healthy skin: Implications for women. Int J Fertil Womens Med. 1999; 44: 83–95
- Laube S, Lanigan SW. Laser treatment of rosacea. J Cosmet Dermatol. 2002; 1: 188–95
- Feldman SR, Hollar CB, Gupta AK, Fleischer AB, Jr. Women commonly seek care for rosacea: Dermatologists frequently provide the care. Cutis. 2001; 68: 156–60
- Kirkland CR, Yelverton CB, Fleischer AB, Jr, Camacho FT, Feldman SR. Gel vehicles are not inherently more irritating than creams. J Drugs Dermatol. 2006; 5: 269–72
- American Medical Association, CPT Code/Relative Value Search. Accessed October 28, 2007. URL:. https://catalog.ama-assn.org/Catalog/cpt/cpt_search.jsp.
- Murray L, Philippi E. 2006 Red book: Pharmacy's fundamental reference. Thomson PDR, Montvale 2006
- Wolf JE, Jr, Kerrouche N, Arsonnaud S. Efficacy and safety of once-daily metronidazole 1% gel compared with twice-daily azelaic acid 15% gel in the treatment of rosacea. Cutis. 2006; 77: 3–11
- Sauder DN, Miller R, Gratton D, Danby W, Griffiths C, Phillips SB. The treatment of rosacea: The safety and efficacy of sodium sulfacetamide 10% and sulfur 5% lotion (Novacet) is demonstrated in a double-blind study. J Dermatolog Treat. 1997; 8: 79–85
- Bleicher PA, Charles JH, Sober AJ. Topical metronidazole therapy for rosacea. Arch Dermatol. 1987; 123: 609–14
- Bjerke R, Fyrand O, Graupe K. Double-blind comparison of azelaic acid 20% cream and its vehicle in treatment of papulo-pustular rosacea. Acta Derm Venereol. 1999; 79: 456–9
- Sneddon IB. A clinical trial of tetracycline in rosacea. Br J Dermatol. 1966; 78: 649–52
- CollaGenex Pharmaceuticals, Inc. Oracea package insert. October 29, 2007.
- Ertl GA, Levine N, Kligman AM. A comparison of the efficacy of topical tretinoin and low-dose oral isotretinoin in rosacea. Arch Dermatol. 1994; 130: 319–24
- Elewski BE, Fleischer AB, Jr, Pariser DM. A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: Results of a randomized trial. Arch Dermatol. 2003; 139: 1444–50
- Ziel K, Yelverton CB, Balkrishnan R, Feldman SR. Cumulative irritation potential of metronidazole gel compared to azelaic acid gel after repeated applications to healthy skin. J Drugs Dermatol. 2005; 4: 727–31
- Galderma Laboratories, L.P. Metrogel 1% package insert. October 29, 2007.
- Galderma Laboratories, L.P. Metrogel 0.75% package insert. October 29, 2007.
- Thiboutot D, Thieroff-Ekerdt R, Graupe K. Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: Results from two vehicle-controlled, randomized phase III studies. J Am Acad Dermatol. 2003; 48: 836–45